Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms)

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00051798" target="_blank" >RIV/00216224:14110/11:00051798 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00209805:_____/11:#0000243

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms)

Popis výsledku v původním jazyce

A malignant pericardial effusion and a cardiac tamponade are known life-threatening complications in cancer patients. An early recognition and a prompt treatment may dramatically relieve patients of symptoms and decrease a short-term risk of death from the effusion. Although the pericardial involvement by malignancy is the leading cause, other etiological factors need exclusion before the final treatment strategy is determined. The treatment of malignant pericardial effusions must be individualized witha consideration given to the patient?s condition and tumor type, the success rates and risks of the various treatment modalities, and their local availability and expertise. The initial relief of symptoms is achieved, in most cases, with a percutaneouspericardiocentesis. A subsequent drainage of the pericardial effusion with an indwelling catheter and a local sclerotherapy and/or chemotherapy alleviates the effusion without recurrence in most of the patients.

Název v anglickém jazyce

Malignant Pericardial Effusion and Cardiac Tamponade (Cardiac and Pericardial Symptoms)

Popis výsledku anglicky

A malignant pericardial effusion and a cardiac tamponade are known life-threatening complications in cancer patients. An early recognition and a prompt treatment may dramatically relieve patients of symptoms and decrease a short-term risk of death from the effusion. Although the pericardial involvement by malignancy is the leading cause, other etiological factors need exclusion before the final treatment strategy is determined. The treatment of malignant pericardial effusions must be individualized witha consideration given to the patient?s condition and tumor type, the success rates and risks of the various treatment modalities, and their local availability and expertise. The initial relief of symptoms is achieved, in most cases, with a percutaneouspericardiocentesis. A subsequent drainage of the pericardial effusion with an indwelling catheter and a local sclerotherapy and/or chemotherapy alleviates the effusion without recurrence in most of the patients.

Druh

C - Kapitola v odborné knize

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

The MASCC Textbook of Cancer Supportive Care and Survivorship

ISBN

978-1-4419-1224-4

Počet stran výsledku

10

Strana od-do

83-92

Počet stran knihy

420

Název nakladatele

Springer

Místo vydání

New York

Kód UT WoS kapitoly

—